LXEO Richard Nolan Townsend sells $313K worth of shares
Apr 08, 2026, 4:39 AM
0.00%
What does LXEO do
Lexeo Therapeutics, a New York City-based genetic medicine company, focuses on therapies for hereditary and acquired diseases and recently went public on November 3, 2023. Its pipeline includes cardiovascular candidates LX2006 and LX2020, both undergoing clinical evaluation.
Richard Nolan Townsend sold 55,000 shares of LXEO on 6 April at $5.69 per share, worth a total of $313K. They now own 340,106 LXEO shares, or a 14% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.